Drug Development

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Articles

Common challenges and key considerations when developing a freeze-drying cycle for protein pharmaceuticals.

Freeze Drying Protein Formulations

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

New formulations and expanded vaccine production are encouraged.

Demand for New Vaccines Spurs Innovation

Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.

Gallus BioPharmaceuticals Enters Agreement with Omni Bio Pharmaceutical

TAP Biosystems announced that Gallus BioPharmaceuticals is using its ambr15 micro bioreactor system to optimize process development and clone selection of novel antibody therapeutics and biosimilars.

Gallus BioPharmaceuticals Uses ambr15 Micro Bioreactor to Develop Novel Antibodies and Biosimilars

Experts share insights on how product appearance such as size, shape, color, and imprint can make a difference in reducing medication errors.

Safety by Design—Mitigating the Risk of Medication Errors Through Product Design

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Lifecycle management opportunities are impacting the development of controlled-release technologies for solid-dosage drugs.

Controlled-Release Technologies Create Opportunities for Solid-Dosage Drug Formulators

The author examines the effect of compaction force, gap width, and sieve setup on granule size.

Obtaining User-Defined Particle Size Distribution Using Dry Granulation

FDA develops an assay that could speed the release of pandemic influenza vaccines.

FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs

Joan FitzPatrick is director of Business Development and Scientific Affairs at Freund Pharmatec, Unit 1, IDA Business & Technology Park, Srah, Tullamore, Co. Offaly, Ireland, email: joan.fitzpatrick@freundpharmatec.com.

Encapsulation technologies for solubility/bioavailability enhancement, controlled release, and formulation of drug combinations and patient-friendly dosage forms.

Formulation and Drug Delivery